Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

Accurate diagnosis is crucial for effective treatment of hair loss.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.